Clinical Trial

Health Systems and Policy Contexts of Medical Oxygen

Study acronym: MOXY-HSP
Recruiting
View on ClinicalTrials.gov →
Summary
This is a mixed-methods program evaluation from a health systems and policy perspective, involving (i) stakeholder analysis, (ii) policy-implementation gap analysis, and (iii) comparative country case studies. This study aims to understand how national oxygen strategies achieve impact at national, and subnational level, across country contexts, at what cost. The the investigators seek to: 1. Involve policymakers, implementers (including private sector), and medical oxygen users in identifying challenges and understanding potential solutions to medical oxygen access; 2. Generate new data on how medical oxygen systems work and can be improved from multiple perspectives; 3. Draw lessons on medical oxygen that can directly inform national and global practice and policy. This study will be conducted in 6 of the 9 countries participating in the Clinton Health Access Initiative (CHAI) led Medical Oxygen Implementation (MOXY) program (Uganda, Nigeria, Rwanda, Liberia, Lao PDR, Cambodia). Key informants will be selected representing government, non-governmental agencies, professional associations, private sector, and civil society. This study will be completed over 4 years, with timelines varying between country study sites.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-12-05; most recent amendment 2026-02-04.
Status change: Not Yet Recruiting → Recruiting 2024-08-27
Trial Details
NCT Number NCT06169514
Lead Sponsor Murdoch Childrens Research Institute
Collaborators: University of Ibadan, University of Health Sciences, Lao People's Democratic Republic (PDR), University of Health Sciences, Cambodia, Makerere University, Ministry of Health, Liberia, Ministry of Health, Rwanda, Karolinska Institutet
Conditions Hypoxemia, Morality, Pneumonia
Enrollment 1 participants
Start Date 2024-07-31
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-06